Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021

Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021

Abstract Over the past decade, immunotherapy has become an increasingly fundamental modality in the treatment of cancer. The positive impact of immune checkpoint inhibition, especially anti-programmed death (PD)-1/PD-ligand (L)1 blockade, in patients with different cancers has focused attention on t...

Повний опис

Бібліографічні деталі
Автори: Paolo A. Ascierto, Antonio Avallone, Nina Bhardwaj, Carlo Bifulco, Sergio Bracarda, Joshua D. Brody, Luigi Buonaguro, Sandra Demaria, Leisha A. Emens, Robert L. Ferris, Jérôme Galon, Samir N. Khleif, Christopher A. Klebanoff, Tamara Laskowski, Ignacio Melero, Chrystal M. Paulos, Sandro Pignata, Marco Ruella, Inge Marie Svane, Janis M. Taube, Bernard A. Fox, Patrick Hwu, Igor Puzanov
Формат: Стаття
Мова:English
Опубліковано: BMC 2022-06-01
Серія:Journal of Translational Medicine
Предмети:
Immunotherapy
Checkpoint inhibitors
Combination therapy
Biomarkers
Tumor microenvironment
Vaccine
Онлайн доступ:https://doi.org/10.1186/s12967-022-03471-y

Інтернет

https://doi.org/10.1186/s12967-022-03471-y

Схожі ресурси